LCL Resources Limited (ASX:LCL)
Australia · Delayed Price · Currency is AUD
0.0060
0.00 (0.00%)
Aug 1, 2025, 10:06 AM AEST
Verve Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
---|
| 2.78 | 3.72 | 8.4 | 19.25 | 7.81 | |
Cash & Short-Term Investments | 2.78 | 3.72 | 8.4 | 19.25 | 7.81 | |
| -25.22% | -55.76% | -56.37% | 146.36% | 22741.51% | |
| 0.12 | 0.23 | 0.16 | 0.05 | 0.06 | |
| 0.12 | 0.23 | 0.16 | 0.05 | 0.06 | |
| 0.08 | 0.16 | 0.29 | 0.08 | 0.17 | |
| 2.98 | 4.1 | 8.85 | 19.39 | 8.05 | |
Property, Plant & Equipment | 13.63 | 13.73 | 27.7 | 26.25 | 19.99 | |
|
| 0.2 | 0.16 | 0.38 | 0.1 | 0.07 | |
| 0.01 | 0.19 | 0.2 | 0.21 | 0.15 | |
| - | - | - | - | 0.05 | |
Other Current Liabilities | 0.13 | 0.45 | 0.1 | 0.48 | 0.42 | |
Total Current Liabilities | 0.34 | 0.8 | 0.68 | 0.79 | 0.69 | |
Other Long-Term Liabilities | - | 0.03 | 0.04 | 0.02 | - | |
|
| 401.67 | 399.44 | 394.36 | 390.96 | 367.42 | |
| -387.04 | -386.94 | -355.92 | -345.05 | -343.13 | |
Comprehensive Income & Other | 1.65 | 4.5 | -2.61 | -1.08 | 3.05 | |
| 16.27 | 17 | 35.83 | 44.83 | 27.35 | |
| -0 | -0 | -0 | -0 | - | |
|
Total Liabilities & Equity | 16.61 | 17.83 | 36.55 | 45.64 | 28.04 | |
| - | - | - | - | 0.05 | |
| 2.78 | 3.72 | 8.4 | 19.25 | 7.76 | |
| -25.22% | -55.76% | -56.37% | 147.94% | - | |
| 0.00 | 0.00 | 0.01 | 0.04 | 0.03 | |
Filing Date Shares Outstanding | 1,195 | 951.15 | 715.71 | 636.72 | 468.78 | |
Total Common Shares Outstanding | 1,195 | 951.15 | 715.71 | 636.72 | 468.78 | |
| 2.64 | 3.3 | 8.17 | 18.6 | 7.36 | |
| 0.01 | 0.02 | 0.05 | 0.07 | 0.06 | |
| 16.27 | 17 | 35.83 | 44.83 | 27.35 | |
Tangible Book Value Per Share | 0.01 | 0.02 | 0.05 | 0.07 | 0.06 | |
| 0.52 | 0.54 | 0.43 | 0.48 | 0.54 | |
| 0.61 | 1.03 | 0.83 | 1.18 | 1.11 | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.